Wordt geladen...
Future challenges and therapeutic opportunities in type 2 diabetes: Changing the paradigm of current therapy
Most algorithms for type 2 diabetes mellitus (T2DM) do not recommend treatment escalation until glycated haemoglobin (HbA1c) fails to reach the recommended target of 7% (53 mmol/mol) within approximately 3 months on any treatment regimen (“treat to failure”). Clinical inertia and/or poor adherence t...
Bewaard in:
| Gepubliceerd in: | Diabetes Obes Metab |
|---|---|
| Hoofdauteurs: | , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Blackwell Publishing Ltd
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5637910/ https://ncbi.nlm.nih.gov/pubmed/28432748 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.12977 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|